Volume 79, Issue 11 pp. 841-843

Cyanoacrylate embolization of endoleaks after abdominal aortic aneurysm repair

Timothy Buckenham

Corresponding Author

Timothy Buckenham

Department of Radiology and

Professor Timothy Michael Buckenham, Department of Radiology, Christchurch Hospital, Private Bag 4710, Christchurch 8140, New Zealand. Email: [email protected]Search for more papers by this author
Michael McKewen

Michael McKewen

Department of Radiology and

Search for more papers by this author
Andrew Laing

Andrew Laing

Department of Radiology and

Search for more papers by this author
Justin Roake

Justin Roake

Department of Vascular, Endovascular & Transplant Surgery, Christchurch Hospital, Christchurch, New Zealand and

Search for more papers by this author
David Lewis

David Lewis

Department of Vascular, Endovascular & Transplant Surgery, Christchurch Hospital, Christchurch, New Zealand and

Search for more papers by this author
Malcolm K. Gordon

Malcolm K. Gordon

Department of General and Vascular Surgery, Christchurch Hospital, Christchurch, New Zealand

Search for more papers by this author
First published: 06 November 2009
Citations: 12

T. M. Buckenham MB ChB, FRANZCR, FRCR; M. McKewen MB ChB; A. Laing MB ChB, FRANZCR; J. Roake MB ChB, FRACS; D. LewisMB ChB, MD, EBSQ(Vasc Surg), FRACS(Vasc Surg), FRCS; M. K. Gordon MB ChB, FRACS.

Abstract

Introduction: Type II endoleaks occur in up to a fifth of endoluminal repairs for abdominal aortic aneurysms and are commonly treated when aortic sac expansion can be demonstrated. Technical failure is common when catheter-guided particulates or coil embolic agents are used. Presented here is a feasibility study using catheter-directed N-butyl-2-cyanoacrylate (Histoacryl, Braun, Tuttlingen, Germany) embolotherapy.

Method: A retrospective review of the case notes of patients undergoing embolization procedures for type II endoleaks with expanding sacs was performed from this centre's cohort of endoluminal aortic repair patients under surveillance. Data on patients with type II endoleaks who were treated with either or both cyanoacrylate and coil embolization were extracted. The outcomes were then compared.

Results: In total, five cases were identified, and four of these cases had both coil and glue embolization. Technical success was defined as endoleak closure proven on follow-up computed tomographic imaging. Technical success was achieved in all four patients treated with intra-sac cyanoacrylate. One case treated initially with coil embolization was successful. All patients had a computed tomographic scan at 3 months. One minor complication occurred that resolved without treatment.

Discussion: Type II endoleaks after EVAR with expanding sacs require treatment. Percutaneous catheter-directed cyanoacrylate embolization offers an alternative to coil or particulate embolization and, in this series, was found to be more likely to result in endoleak closure.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.